Novel Inhibition of AKR1C3 and Androgen Receptor Axis by PTUPB Synergizes Enzalutamide Treatment in Advanced Prostate Cancer

Researchers reported that the level of AKR1C3 was reciprocally regulated by the full-length androgen receptor through binding to the distal enhancer region of the AKR1C3 gene.